These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33260956)

  • 1. Vaccination against β-Amyloid as a Strategy for the Prevention of Alzheimer's Disease.
    Mantile F; Prisco A
    Biology (Basel); 2020 Nov; 9(12):. PubMed ID: 33260956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid beta peptide immunotherapy in Alzheimer disease.
    Delrieu J; Ousset PJ; Voisin T; Vellas B
    Rev Neurol (Paris); 2014 Dec; 170(12):739-48. PubMed ID: 25459121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization in Alzheimer's disease: naïve hope or realistic clinical potential?
    Foster JK; Verdile G; Bates KA; Martins RN
    Mol Psychiatry; 2009 Mar; 14(3):239-51. PubMed ID: 18957942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A beta immunotherapy: Lessons learned for potential treatment of Alzheimer's disease.
    Schenk DB; Seubert P; Grundman M; Black R
    Neurodegener Dis; 2005; 2(5):255-60. PubMed ID: 16909006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
    Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
    Immunotherapy; 2012 Feb; 4(2):213-38. PubMed ID: 22339463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention.
    Cribbs DH
    CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):207-16. PubMed ID: 20205639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fresh perspective from immunologists and vaccine researchers: active vaccination strategies to prevent and reverse Alzheimer's disease.
    Agadjanyan MG; Petrovsky N; Ghochikyan A
    Alzheimers Dement; 2015 Oct; 11(10):1246-59. PubMed ID: 26192465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current trend of immunotherapy for Alzheimer's disease].
    Matsumoto SE; Tabira T
    Nihon Rinsho; 2011 Sep; 69(9):1628-32. PubMed ID: 21922765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological approaches for amyloid-beta clearance toward treatment for Alzheimer's disease.
    Solomon B
    Rejuvenation Res; 2008 Apr; 11(2):349-57. PubMed ID: 18341423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developing injectable immunoglobulins to treat cognitive impairment in Alzheimer's disease.
    Steinitz M
    Expert Opin Biol Ther; 2008 May; 8(5):633-42. PubMed ID: 18407766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral amyloid angiopathy and microhemorrhages after amyloid beta vaccination: case report and brief review.
    Uro-Coste E; Russano de Paiva G; Guilbeau-Frugier C; Sastre N; Ousset PJ; da Silva NA; Lavialle-Guillotreau V; Vellas B; Delisle MB
    Clin Neuropathol; 2010; 29(4):209-16. PubMed ID: 20569670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active Amyloid-β Vaccination Results in Epigenetic Changes in the Hippocampus of an Alzheimer's Disease-Like Mouse Model.
    Lardenoije R; van den Hove DLA; Jung SE; Havermans M; Blackburn P; Liu B; Rutten BPF; Lemere CA
    Curr Alzheimer Res; 2019; 16(9):861-870. PubMed ID: 31453788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?
    Panza F; Logroscino G; Imbimbo BP; Solfrizzi V
    Curr Opin Psychiatry; 2014 Mar; 27(2):128-37. PubMed ID: 24445401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New developments of clinical trial in immunotherapy for Alzheimer's disease.
    Yang C; Xiao S
    Curr Pharm Biotechnol; 2015; 16(6):484-91. PubMed ID: 25860060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Molecules in Alzheimer's Disease: Therapeutic Antibodies.
    Solomon B
    Drug News Perspect; 2002 Sep; 15(7):410-416. PubMed ID: 12677176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Abeta vaccine therapy for Alzheimer's disease].
    Hara H
    Rinsho Shinkeigaku; 2005 Nov; 45(11):867-9. PubMed ID: 16447748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for Alzheimer's disease: rational basis in ongoing clinical trials.
    Menéndez-González M; Pérez-Piñera P; Martínez-Rivera M; Muñiz AL; Vega JA
    Curr Pharm Des; 2011; 17(5):508-20. PubMed ID: 21375481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validating Immunotherapy in Alzheimer's Disease: The EB101 Vaccine.
    Carrera I; Fernandez-Novoa L; Aliev G; Vigo C; Cacabelos R
    Curr Pharm Des; 2016; 22(7):849-58. PubMed ID: 26648469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease immunotherapy: from in vitro amyloid immunomodulation to in vivo vaccination.
    Solomon B
    J Alzheimers Dis; 2006; 9(3 Suppl):433-8. PubMed ID: 16914882
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.